Royal Bank of Canada’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $66.1M | Sell |
944,457
-54,883
| -5% | -$2.84M | 0.01% | 853 |
|
|
2026
Q1 | $50.8M | Sell |
999,340
-144,440
| -13% | -$6.74M | 0.01% | 908 |
|
|
2025
Q4 | $33.7M | Sell |
1,143,780
-513,785
| -31% | -$14M | 0.01% | 1145 |
|
|
2025
Q3 | $42.8M | Sell |
1,657,565
-1,212,848
| -42% | -$33.8M | 0.01% | 1101 |
|
|
2025
Q2 | $79.2M | Buy |
2,870,413
+1,921,323
| +202% | +$50.6M | 0.01% | 724 |
|
|
2025
Q1 | $26.9M | Buy |
949,090
+165,506
| +21% | +$5.87M | 0.01% | 1121 |
|
|
2024
Q4 | $32.6M | Buy |
783,584
+153,617
| +24% | +$7.34M | 0.01% | 1051 |
|
|
2024
Q3 | $42.1M | Sell |
629,967
-7,358
| -1% | -$676K | 0.01% | 902 |
|
|
2024
Q2 | $75.7M | Sell |
637,325
-20,920
| -3% | -$2.65M | 0.02% | 611 |
|
|
2024
Q1 | $70.1M | Sell |
658,245
-69,114
| -10% | -$6.97M | 0.02% | 655 |
|
|
2023
Q4 | $72.3M | Buy |
727,359
+179,759
| +33% | +$15.1M | 0.02% | 626 |
|
|
2023
Q3 | $56.6M | Buy |
547,600
+32,902
| +6% | +$3.67M | 0.02% | 646 |
|
|
2023
Q2 | $62.5M | Buy |
514,698
+90,973
| +21% | +$12.1M | 0.02% | 623 |
|
|
2023
Q1 | $65.1M | Sell |
423,725
-271,588
| -39% | -$44.8M | 0.02% | 590 |
|
|
2022
Q4 | $125M | Buy |
695,313
+225,528
| +48% | +$36.9M | 0.04% | 413 |
|
|
2022
Q3 | $55.6M | Buy |
469,785
+75,684
| +19% | +$11.5M | 0.02% | 607 |
|
|
2022
Q2 | $56.3M | Buy |
394,101
+11,769
| +3% | +$1.68M | 0.02% | 623 |
|
|
2022
Q1 | $65.9M | Sell |
382,332
-291,308
| -43% | -$49M | 0.02% | 648 |
|
|
2021
Q4 | $171M | Buy |
673,640
+290,055
| +76% | +$84.8M | 0.04% | 365 |
|
|
2021
Q3 | $148M | Buy |
383,585
+99,433
| +35% | +$36.7M | 0.04% | 376 |
|
|
2021
Q2 | $66.8M | Buy |
284,152
+31,662
| +13% | +$5.66M | 0.02% | 617 |
|
|
2021
Q1 | $33.1M | Sell |
252,490
-10,795
| -4% | -$1.56M | 0.01% | 938 |
|
|
2020
Q4 | $27.5M | Buy |
263,285
+129,950
| +97% | +$13.1M | 0.01% | 1038 |
|
|
2020
Q3 | $9.43M | Buy |
133,335
+22,681
| +20% | +$1.58M | ﹤0.01% | 1585 |
|
|
2020
Q2 | $7.1M | Buy |
110,654
+8,824
| +9% | +$483K | ﹤0.01% | 1707 |
|
|
2020
Q1 | $3.05M | Buy |
101,830
+18,322
| +22% | +$422K | ﹤0.01% | 2155 |
|
|
2019
Q4 | $1.63M | Sell |
83,508
-9,141
| -10% | -$162K | ﹤0.01% | 3057 |
|
|
2019
Q3 | $1.48M | Sell |
92,649
-39,768
| -30% | -$587K | ﹤0.01% | 3006 |
|
|
2019
Q2 | $1.94M | Buy |
132,417
+19,828
| +18% | +$426K | ﹤0.01% | 2801 |
|
|
2019
Q1 | $2.29M | Sell |
112,589
-24,760
| -18% | -$460K | ﹤0.01% | 2576 |
|
|
2018
Q4 | $2.1M | Buy |
+137,349
| New | +$2.26M | ﹤0.01% | 2609 |
|
Other funds holding MRNA
TP
Royal Bank of Canada's MRNA Position: Q2 2026 in Review
Royal Bank of Canada reduced its Moderna (MRNA) stake by 5.5% in Q2 2026, selling an estimated $2.84M and leaving 944,457 shares worth $66.1M. The position accounts for 0.01% of the portfolio, ranked #853.
Royal Bank of Canada first reported a position in MRNA in Q4 2018 and has held it in 31 quarters since. The position peaked at $171M in Q4 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Royal Bank of Canada held 944,457 shares of Moderna worth $66.1M as of Q2 2026.
- Royal Bank of Canada sold 54,883 Moderna shares in Q2 2026, an estimated $2.84M.
- Moderna made up 0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #853 holding.
- Royal Bank of Canada first reported a position in Moderna in Q4 2018 and has held it in 31 quarters since.
- Royal Bank of Canada's Moderna position peaked at $171M in Q4 2021.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.